Kara L. Mungovan
Lawyers
Filters
Turn Therapeutics direct listing
We advised Turn Therapeutics on its Nasdaq listing
Pague Menos R$243.5 million follow-on offering
We advised Pague Menos on the offering
DuPont exchange offers and consent solicitations
The exchange offers included the issuance of new notes due 2028, 2038 and 2048
Neptune $368 million IPO
The shares are listed on the New York Stock Exchange
Cipher Mining 168 MW, 10-year AI hosting agreement with Fluidstack
We advised Cipher Mining on the transaction
Energizer Holdings $400 million notes offering
The high-yield notes are due 2033
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
GrowthCurve Capital acquisition of PlanHub
We advised GrowthCurve Capital on the transaction
Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering